adapa bundles information in digital packaging

At Fachpack in September, the adapa Group will be presenting a new field of activity that is intended to contribute to the topic of sustainability.

At Fachpack in September, the adapa Group will be presenting a new field of activity that focuses on the topic of sustainability. The keyword is ‚digital packaging‘. The „everload“ technology makes information tangible for stakeholders.

„Most companies want to expand their ESG initiatives and generally increase their efforts to strengthen sustainability. With this in mind, I am delighted that we at adapa are now able to offer our new product „everload“ to the market. With this technology, we are in a position to analyse relevant assigning data from flexible packaging to our products, reading it out and tracing it.“
 
Dr Stefan Biel, Head of Innovation at adapa

Always endeavouring to stay one step ahead with technological solutions, the adapa has now tapped into the potential of digitalisation in flexible packaging. This New dimension of information transparency drives the circular economy in the packaging industry forward.

„At adapa, we want to make a difference and believe that everload can be a game changer. Knowledge is power - and with more knowledge and more transparency throughout the value chain, we see the opportunity to take sustainability to a whole new level. With everload, all the necessary data will be open and accessible to all stakeholders, which also means that carbon footprint measurements, for example, will be easier to carry out.“

Dr Stefan Biel 

Display

At the same time, companies receive More control through easier data management and an increase in knowledge. In addition, you can also benefit from a reduced regulatory burden and automated data reporting.

Source: adapa

More news on digitalisation

Sea Vision founds subsidiary in Frankfurt

The Sea Vision Group has opened a new subsidiary in Frankfurt with the establishment of Sea Vision Germany - the third European branch after Italy and Spain. It is intended to further consolidate the company's position in the key markets of the pharmaceutical and biotech industry.
Read more "